84
Views
0
CrossRef citations to date
0
Altmetric
Resident Report

Delayed Metastasis of Clear Cell Sarcoma of Kidney to Bladder After 7 Disease-Free Years

&
Pages 126-133 | Received 05 Jan 2018, Accepted 23 Jan 2018, Published online: 06 Mar 2018

References

  • Wasilewski-Masker K, Liu Q, Yasui Y, et al. Late recurrence in pediatric cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst. 2009;101:1709–20. doi:10.1093/jnci/djp417. PMID: 19966206.
  • Kitajima K, Bardier-Dupas A, Breton S, et al. Variant on manifestation of duodenal metastasis 26 years after initial diagnosis of primary cutaneous melanoma. Case Rep Gastroenterol, 2010;4:93–9. doi:10.1159/000290383. PMID: 21103234.
  • Cimatti M, Salvati M, Caroli E, et al. Extremely delayed cerebral metastasis from renal carcinoma: report of four cases and critical analysis of the literature. Tumori. 2004;90:342–4. PMID: 15315318.
  • Argani P, Beckwith JB. Renal neoplasms of childhood. In: Mills SE, ed. Sternberg's diagnostic surgical pathology. Sixth edition. Philadelphia: Wolters Kluwer, 2015. p. 2034–2038.
  • Florine BL, Simonton SC, Sane SM, Stickel FR, Singher LJ, Dehner LP. Clear cell sarcoma of the kidney: report of a case with mandibular metastasis simulating a benign myxomatous tumor. Oral Surg Oral Med Oral Pathol. 1988;65:567–74. doi:10.1016/0030-4220(88)90139-9. PMID: 3287257.
  • Mirkovic J, Calicchio M, Fletcher CD, Perez-Atayde AR. Diffuse and strong cyclin D1 immunoreactivity in clear cell sarcoma of the kidney. Histopathology. 2015;67:306–12. doi:10.1111/his.12641. PMID: 25556515.
  • Argani P, Perlman EJ, Breslow NE, et al. Clear cell sarcoma of the kidney: a review of 351 cases from the National Wilms Tumor Study Group Pathology Center. Am J Surg Pathol. 2000;24:4–18. doi:10.1097/00000478-200001000-00002. PMID: 10632483.
  • Vujanic GM. Renal tumours of childhood: an overview. Diagn Histopathol. 2009;15:501–9. doi:10.1016/j.mpdhp.2009.08.002.
  • Furtwängler R, Gooskens SL, van Tinteren H, et al. Clear cell sarcomas of the kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: a report of the SIOP Renal Tumour Study Group. Eur J Cancer. 2013;49:3497–506. doi:10.1016/j.ejca.2013.06.036. PMID: 23880476.
  • Gooskens SL, Furtwängler R, Spreafico F, et al. Treatment and outcome of patients with relapsed clear cell sarcoma of the kidney: a combined SIOP and AIEOP study. Br J Cancer. 2014;111:227–33. doi:10.1038/bjc.2014.291. PMID: 24937667.
  • Parikh SH, Chintagumpala M, Hicks JM, et al. Clear cell sarcoma of the kidney: an unusual presentation and review of the literature. J Pediatr Hematol Oncol. 1998;20:165–8. doi:10.1097/00043426-199803000-00016. PMID: 9544171.
  • Huppmann AR, Pawel BR. Polyps and masses of the pediatric urinary bladder: a 21-year pathology review. Pediatr Dev Pathol. 2011;14:438–44. doi:10.2350/11-01-0958-OA.1. PMID: 21793666.
  • Jones C, Rodriguez-Pinilla M, Lambros M, et al. C-Kit overexpression, without gene amplification and mutation, in paediatric renal tumours. J Clin Pathol. 2007;60:1226–31. doi:10.1136/jcp.2007.046441. PMID: 17965221.
  • Jet Aw J, Hong CK, Hwee MY, et al. Novel karyotypes and cyclin D1 immunoreactivity in clear cell sarcoma of the kidney. Pediatr Dev Pathol. 2015;18:297–304. doi:10.2350/14-12-1581-OA.1. PMID: 25751590.
  • Magro G, Salvatorelli L, Alaggio R, et al. Diagnostic utility of cyclin D1 in the diagnosis of small round blue cell tumors in children and adolescents. Hum Pathol. 2017;60:58–65. doi:10.1016/j.humpath.2016.07.038. PMID: 27984122.
  • Cutcliffe C, Kersey D, Huang CC, et al. Clear cell sarcoma of the kidney: up-regulation of neural markers with activation of the sonic hedgehog and Akt pathways. Clin Cancer Res. 2005;11:7986–94. doi:10.1158/1078-0432.CCR-05-1354. PMID: 16299227.
  • Roy A, Kumar V, Zorman B, et al. Recurrent internal tandem duplications of BCOR in clear cell sarcoma of the kidney. Nat Commun. 2015;6:8891. doi:10.1038/ncomms9891. PMID: 26573325.
  • Astolfi A, Melchionda F, Perotti D, et al. Whole transcriptome sequencing identified BCOR internal tandem duplication as a common feature of clear cell sarcoma of the kidney. Oncotarget. 2015;6:40934–9. doi:10.18632/oncotarget.5882. PMID: 26516930.
  • Gooskens SL, Gadd S, van den Heuvel-Eibrink MM, Perlman EJ. BCOR internal tandem duplications in clear cell sarcoma of the kidney. Genes Chromosomes Cancer. 2016;55:549–50. doi:10.1002/gcc.22353. PMID: 26874462.
  • Kenny C, Bausenwein S, Lazaro A, et al. Mutually exclusive BCOR internal tandem duplications and YWHAE-NUTM2 fusions in clear cell sarcoma of kidney: not the full story. J Pathol. 2016;238:617–20. doi:10.1002/path.4693. PMID: 27000436.
  • Wong MK, Ng CCY, Kuick CH, et al. Clear cell sarcoma of kidney are characterized by BCOR gene abnormalities including exon 15 internal tandem duplications and BCOR-CCNB3 gene fusion. Histopathology. 2017, Aug 18. doi: 10.111/his.13366 [Epub ahead of print].
  • Santiago T, Clay MR, Azzato E, et al. Clear cell sarcoma of kidney involving a horseshoe kidney and harboring EGFR internal tandem duplication. Pediatr Blood Cancer. 2017. doi: 10.1002/pbc.26602 [Epub ahead of print].
  • Kao YC, Sung YS, Zhang L, et al. Recurrent BCOR internal tandem duplication and YWHAE-NUTM2B fusions in soft tissue undifferentiated round cell sarcoma of infancy: overlapping genetic features with clear cell sarcoma of kidney. Am J Surg Pathol. 2016;40:1009–20. doi:10.1097/PAS.0000000000000629. PMID: 26945340.
  • Sturm D, Orr BA, Toprak UH, et al. New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell. 2016;164:1060–72. doi:10.1016/j.cell.2016.01.015. PMID: 26919435.
  • Santiago T, Clay MR, Allen SJ, Orr BA. Recurrent BCOR internal tandem duplication and BCOR or BCL6 expression distinguish primitive myxoid mesenchymal tumor of infancy from congenital infantile fibrosarcoma. Mod Pathol. 2017;30:884–91. doi:10.1038/modpathol.2017.12. PMID: 28256570.
  • Argani P, Kao YC, Zhang L, et al. Primary renal sarcomas with BCOR-CCNB3 gene fusion: a report of 2 cases showing histologic overlap with clear cell sarcoma of kidney, suggesting further link between BCOR-related sarcomas of the kidney and soft tissues. Am J Surg Pathol. 2017;41:1702–12. doi:10.1097/PAS.0000000000000926.
  • Kusumakumary P, Chellam VG, Rojymon J, Hariharan S, Krishnan NM. Late recurrence of clear cell sarcoma of the kidney. Med Pediatr Oncol. 1997;28:355–7. doi:10.1002/(SICI)1096-911X(199705)28:5%3c355::AID-MPO5%3e3.0.CO;2-G. PMID: 9121400.
  • Fernandez CV, Geller JI, Ehrlich PF, et al. Renal tumors. In: Pizzo PA, Poplack DG, eds. Principles and practice of pediatric oncology. Seventh edition. Philadelphia: Wolters Kluwer; 2016. p. 766–767.
  • Robison LL, Hudson MM. Survivors of childhood and adolescent cancer: life-long risks and responsibilities. Nat Rev Cancer. 2014;14:61–70. doi:10.1038/nrc3634. PMID: 24304873.
  • Schroder H, Rechnitzer C, Wehner PS, et al. Danish childhood cancer registry. Clin Epidemiol. 2016;8:461–4. doi:10.2147/CLEP.S99508. PMID: 27822085.
  • AIRTUM Working Group; CCM; AIEOP Working Group. Italian cancer figures, report 2012: cancer in children and adolescents. Epidemiol Prev. 2013;37(1 Suppl 1):1–225.
  • Friedman, DL, Whitton J, Leisenring W, et al. Subsequent neoplasms in 5-year survivors of childhood cancer: the childhood cancer survivor study. J Natl Cancer Inst. 2010;102:1083–95. doi:10.1093/jnci/djq238. PMID: 20634481.
  • Armstrong GT, Liu Q, Yasui Y, et al. Late mortality among 5-year survivors of childhood cancer: a summary from the childhood cancer survivor study. J Clin Oncol. 2009;27:2328–38. doi:10.1200/JCO.2008.21.1425. PMID: 19332714.
  • Armstrong GT, Pan Z, Ness KK, Srivastava D, and Robison LL. Temporal trends in cause-specific late mortality among 5-year survivors of childhood cancer. J Clin Oncol. 2010;28:1224–31. doi:10.1200/JCO.2009.24.4608. PMID: 20124180.
  • Laverdiere C, Liu Q, Yasui Y, et al. Long-term outcomes in survivors of neuroblastoma: a report from the childhood cancer survivor study. J Natl Cancer Inst. 2009;101:1131–40. doi:10.1093/jnci/djp230. PMID: 19648511.
  • Hertel NT, Carlsen N, Kerndrup G, et al. Late relapse of adrenocortical carcinoma in Beckwith-Wiedemann syndrome. Clinical, endocrinological and genetic aspects. Acta Paediatr. 2003;92:439–43. doi:10.1111/j.1651-2227.2003.tb00575.x. PMID: 12801110.
  • Mattke AC, Bailey EJ, Schuck A, et al. Does the time-point of relapse influence outcome in pediatric rhabdomyosarcomas? Pediatr Blood Cancer. 2009;52:772–6. doi:10.1002/pbc.21906. PMID: 19165889.
  • Mertens AC. Cause of mortality in 5-year survivors of childhood cancer. Pediatr Blood Cancer. 2007;48:723–6. doi:10.1002/pbc.21114. PMID: 17226844.
  • Gomis RR, Gawrzak S. Tumor cell dormancy. Mol Oncol. 2016;pii:S1574–7891 [Epub ahead of print].
  • Lee SY, Kim KR, Park JY, Ro JY. Wilms' tumor with long-delayed recurrence: 25 years after initial treatment. Korean J Urol. 2012;53:288–92. doi:10.4111/kju.2012.53.4.288. PMID: 22536475.
  • Norkin M, Uberti JP, Schiffer CA. Very late recurrences of leukemia: why does leukemia awake after many years of dormancy? Leuk Res. 2011;35:139–44. doi:10.1016/j.leukres.2010.09.016. PMID: 20970853.
  • Gooskens SL, Furtwangler R, Vujanic GM, Dome JS, Graf N, van den Heuvel-Eibrink MM. Clear cell sarcoma of the kidney: a review. Eur J Cancer. 2012;48:2219–26 doi:10.1016/j.ejca.2012.04.009. PMID: 22579455.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.